UniPron is A Fully Effective Non-hormonal Reversible Contraceptive in Baboon Model (Papio Anubis)
View/ Open
Date
2008-06Author
Obiero, J A
Mburu, M N
Ndung’u, B M
Waititu, K K
Mulei, I
Farah, I O
Mwethera, P G
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
Objective To determine the safety and efficacy of UniPron as a reversible contraceptive.
Methods Vaginal swabs were obtained before and after UniPron administration,
cultured onto appropriate culture media and bacteria identification was done based
on type of media used, Gram stain reactions, colony morphology and biochemical
tests. Vaginal biopsy tissues were processed using paraffin wax method, stained with
hematoxylin and eosin and examined under light microscopy to determine the effect of
the product on vaginal tissues. The effect of UniPron on sperm was examined by
mixing the product with electroejaculated spermatozoa in vitro at different
concentrations. For efficacy studies, male baboons of proven fertility were mated with
UniPron treated or untreated females of proven fertility during the fertile stages.
Results All the five females (100%) that were treated with UniPron did not conceive
and they regained total fertility when the treatment was stopped while all the controls
conceived. At a concentration of 40%,UniPron completely immobilized spermatozoa
in an in-vitro system. UniPron mechanism of action was by lowering the vaginal pH
and on application in baboon, the pH was lowered for at least 3 h after which it went
back to normal.
Conclusions As we plan for a study to test UniPron as a microbicide to prevent STIs
including HIV, our current study has established that this novel product is effective in
contraception and harmless to vaginal tissues and vaginal microbial flora in a
baboon model (Papio anubis).
Citation
Journal of Reproduction & Contraception 2008 Jun; 19(2):107-118Sponsorhip
This project was supported through a funded project at the Institute of Primate Research, by the Government of Kenya Corresponding author: Peter G. Mwethera; Tel: +254-20-882571/4; Fax: +254-20-882546; E-mail: mwethera@primateresearch.orgPublisher
Department of Reproductive Health and Reproductive Biology, Institute of Primate Research, University of Nairobi, Kenya